Can Your Blood Test Reveal Hidden Infections? A New Way to Spot Neutrophil Activation
"Scientists have discovered a novel method to detect activated neutrophils using standard hematology analyzers, potentially offering earlier insights into bacterial infections and immune responses."
Our bodies have a sophisticated defense system, and at the forefront of that system are neutrophils, a type of white blood cell. These cells are essential for fighting off infections, primarily by engulfing bacteria (phagocytosis) and releasing reactive oxygen species (ROS) to kill pathogens. When an infection occurs, the number of neutrophils increases, and they're called to the site of infection. Understanding how neutrophils function and respond is crucial for managing various health conditions.
Traditionally, identifying activated neutrophils, which are neutrophils that are actively fighting infection, has been complex, often involving specialized imaging techniques. However, a recent study sheds light on a simpler approach. Researchers have found that by using standard hematology analyzers—machines commonly used for routine blood tests—it’s possible to detect activated neutrophils based on their unique characteristics.
This article explores this innovative method, explaining how changes in neutrophil structure, specifically the formation of vacuoles, can be detected using ordinary blood testing equipment. This approach offers the potential for quicker and more accessible diagnosis of bacterial infections and a better understanding of how our immune system responds to threats.
Vacuoles: The Key to Unlocking Neutrophil Activity
The key to this new detection method lies in the observation that activated neutrophils form vacuoles—small, bubble-like structures—within their cytoplasm. These vacuoles are created as part of the process where neutrophils engulf and destroy pathogens. The presence of these vacuoles changes the way light scatters when analyzed by a hematology analyzer, particularly increasing side-scattering (SSC).
- A distinct cluster of cells appeared in the eosinophil area of the analyzer's scattergram, indicating a population with higher side-scattering (SSC).
- These cells were confirmed to be CD16b- and APF-positive, markers of activated neutrophils producing ROS.
- Microscopic analysis (CLSM and EM) revealed the presence of vacuoles within these activated neutrophils.
Signals of Neutrophil Activation
One study measured reactive oxygen species (ROS) production as an indicator of neutrophil and monocyte activation. Another reports that activated neutrophils have greater side scatter (SSC) than resting neutrophils, a difference in a measurable cell characteristic. Research on bovine neutrophils also found differences in major histocompatibility complex class II and CD25 expression between cells derived from milk and blood, pointing to possible antigen-presentation and immune-modulatory properties.
Limits of Neutrophil Function Testing
Neutrophil tests address several distinct functions, and a result focused on one mechanism may not capture all antimicrobial activity. In chronic granulomatous disease, neutrophils have low membrane oxidase activity and are inefficient at killing catalase-positive microorganisms; oxidative-burst measurements are commonly used to assess killing ability. However, neutrophils also have other microbicidal systems. Neutrophil disorders can predispose people to severe or recurrent infections, while quantitative neutropenia—defined in the cited review as 1,500 or fewer polymorphonuclear leukocytes per mm³—is a commonly observed defense-system abnormality.
Comparing Blood-Cell Screening and Function Tests
A study of the CD-1700 hematology analyzer found no significant difference from microscopic examination when mononuclear-cell levels were below 10%; at levels of 10% or higher, the methods differed, and microscopy detected abnormal cells in 15.5% of samples. A separate evaluation says high-quality five-part differential analyzers can be used for screening, but their ability to identify abnormal cell morphology is limited. For assessing neutrophil function, a source describes the direct nitroblue tetrazolium (NBT) assay as usable with as little as 0.1 ml of blood and as quicker and simpler than alternatives, including for children and neonates. A 2023 report also describes whole-blood flow-cytometry assays designed to assess neutrophil activation while retaining soluble mediators that influence function.
The Future of Infection Detection
This research opens up exciting possibilities for diagnosing and monitoring bacterial infections. By using standard hematology analyzers to detect changes in neutrophil structure, doctors may be able to identify infections earlier and more efficiently.
Toward Functional, Real-Time Readouts
A June 29, 2026, Frontiers article describes LIT as capturing the dynamic nature of neutrophil-derived ROS activity. It presents LIT as a real-time functional readout that may distinguish immune activation from conventional inflammatory biomarkers and reflect a potentially distinct innate immune pathway. The supplied article about using common blood-test equipment similarly describes efforts to identify activated neutrophils as a possible route toward quicker diagnosis of bacterial infections, though its snippet does not provide study details or validation results.
Activation Across Disease and Inflammation
A June 15, 2026, editorial reports that blood heparin-binding protein reflects systemic neutrophil activation across autoimmune kidney diseases, with a reported association to disease severity independent of estimated glomerular filtration rate (eGFR). Separately, a review describes how excessive neutrophil activation may lead to aberrant cell death, uncontrolled oxidative bursts, NET formation, and sustained release of inflammatory mediators such as proteases. These sources highlight that neutrophil activity is relevant beyond infection and that excessive activation can contribute to inflammatory disease processes.
Furthermore, this method could improve our understanding of various immune responses. Since neutrophil activation plays a key role in many inflammatory conditions, this technique could be used to monitor disease activity and response to treatment.
While further studies are needed to fully validate this approach, the initial findings are promising. This innovative use of existing technology has the potential to transform how we detect and manage infections, ultimately leading to better patient outcomes.